Inventor · disambiguated record
Joanne B. Weidhaas
Also filed as: WEIDHAAS JOANNE · WEIDHAAS JOANNE B · WEIDHAAS JOANNE BARNES
5 granted patents·19 pending applications·5 citations·filing 2007–2025
70Inventor score
Top patents by PatentIndex Score
24 records- 0178US7741306B2Regulation of oncogenes by microRNAsUNIV YALE·Filed 2007·Granted Jun 22, 2010·4 cites·11 claims
- 0273US12297509B2Biomarkers for predicting tumor response to and toxicity of immunotherapyMIRA DX INC·Filed 2023·Granted May 13, 2025·0 cites·15 claims
- 0367US2025305062A1Biomarkers for predicting tumor response to and toxicity of immunotherapyMIRA DX INC·Filed 2025·Application pending·0 cites
- 0464US8221980B2Genetic lesion associated with cancerSLACK FRANK J·Filed 2010·Granted Jul 17, 2012·1 cites·6 claims
- 0563US11578371B2Biomarkers for predicting tumor response to and toxicity of immunotherapyMIRA DX INC·Filed 2018·Granted Feb 14, 2023·0 cites·14 claims
- 0662US2022088033A1Methods for treating or preventing cancer in a kras-variant patient and for diagnosing risk of developing multiple primary breast tumorsMIRA DX INC·Filed 2021·Application pending·0 cites
- 0760US2014206003A1Genetic Lesion Associated with CancerUNIV YALE·Filed 2014·Application pending·0 cites
- 0857US2013089862A1Genetic Lesion Associated With CancerUNIV YALE·Filed 2012·Application pending·0 cites
- 0957US2015025230A1Single Nucleotide Polymorphisms in BRCA1 and Cancer RiskUNIV YALE·Filed 2013·Application pending·0 cites
- 1055US2012115131A1Genetic lesion associated with cancerSLACK FRANK J·Filed 2008·Application pending·0 cites
- 1151US2019307770A1Methods for treating or preventing cancer in a kras-variant patient and for diagnosing risk of developing multiple primary breast tumorsMIRADX·Filed 2019·Application pending·0 cites
- 1251US2015259752A1Genetic Lesion Associated With CancerUNIV YALE·Filed 2015·Application pending·0 cites
- 1349US2023103419A1Biomarkers for predicting toxicity of radiationMIRA DX INC·Filed 2021·Application pending·0 cites
- 1448US10278976B2Methods for treating or preventing cancer in a KRAS-variant patient and for diagnosing risk of developing multiple primary breast tumorsMIRA DX INC·Filed 2015·Granted May 7, 2019·0 cites·4 claims
- 1546US2012156676A1Single nucleotide polymorphisms in brca1 and cancer riskWEIDHAAS JOANNE B·Filed 2010·Application pending·0 cites
- 1644US2011054006A1Regulation of oncogenes by micrornasUNIV YALE·Filed 2010·Application pending·0 cites
- 1743US2011212021A1Targeted oligonucleotide compositions for modifying gene expressionSLACK FRANK J·Filed 2009·Application pending·0 cites
- 1842US2014024590A1KRAS-Variant And EndometriosisWEIDHAAS JOANNE B·Filed 2012·Application pending·0 cites
- 1940US2013252832A1KRAS Variant and Tumor BiologyWEIDHAAS JOANNE B·Filed 2012·Application pending·0 cites
- 2040US2014065615A1The KRAS Variant and Tumor BiologyWEIDHAAS JOANNE B·Filed 2012·Application pending·0 cites
- 2138US2020325234A1Immune-based treatment of kras-variant cancer patientsMIRA DX INC·Filed 2017·Application pending·0 cites
- 2237US2012219958A1MicroRNA Signatures Differentiating Uterine and Ovarian Papillary Serous TumorsWEIDHAAS JOANNE B·Filed 2010·Application pending·0 cites
- 2337US2013065778A1MicroRNA Signatures Predicting Responsiveness To Anti-HER2 TherapyWEIDHAAS JOANNE B·Filed 2011·Application pending·0 cites
- 2435US2012028254A1SNP Marker of Breast and Ovarian Cancer RiskWEIDHAAS JOANNE B·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →